Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 17, 2021

View Archived Issues

KRAS just wants to help: Pancreatic KRAS mutations may be protection gone bad

CNGA1 behind retinal degeneration, murine model shows

Guanylate cyclase C agonist IW-3300 shows promise for treating visceral pain

Mitokinin discloses PINK1 activators

Bahcesehir Universitesi presents Hdm2 inhibitors

Achillion Pharmaceuticals identifies new complement factor D inhibitors

UCL Business describes new CRP inhibitors

Nanjing Sanhome Pharmaceutical divulges anti-CD47/anti-PD-L1 antibodies

Novel potent TGR5 agonist shows antidiabetic effects in TGR5(H88Y) mutant mice

VU-6028418 reverses cataleptic behavior in rat models

Endeavor BioMedicines licenses rights to ULK1/2 inhibitor for LKB1- and RAS-mutated cancers

Targeting PANX1/IL-33 axis decreases MRSA infection-induced liver damage

RARG rs2229774 genetic variant identifies cardioprotective therapy

Bantam completes seed funding to advance BTM-3566 toward the clinic

Tarveda and SciClone enter license agreement for preclinical PI3K miniature drug conjugates

Targeting RON short form suppresses breast cancer metastasis through subverted immunosuppression

Clarus licenses rights to McGill technology to treat conditions associated with CoQ10 deficiencies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...